.png?width=423&name=MDB_Logo_neuroscience%20(1).png "MDB_Logo_neuroscience (1)"){kind=logo}
Our team of neuroscientists are experts in pain and neurodegeneration and are able to develop complex predictive studies.
Our team has 70 years combined experience to accurately execute methods that characterize disease and enhance therapeutic potential.
We accommodate short lead times, adapt to your changing needs, and deliver mid-study results - feels like we are just down the hall.
PRECLINICAL DEVELOPMENT STUDIES TO
Our team of scientists approach each study design with the clinic in mind. Whether the choice of species, the disease model selected, or the readouts used, we bring innovative methods to increase the translatability of preclinical data. From in vitro mode of action to in vivo efficacy, our GLP-certified laboratory is fully equipped with behavioral suites for assessing cognition, memory, pain, sensorimotor function, and more. In addition to rodent models, we offer pig models to further bridge the gap between preclinical and clinical studies.
CLINICALLY RELEVANT DATA IS ENHANCED BY
We understand that clinically relevant preclinical data is enhanced by the use of outcomes comparable to those measured in patients. We go beyond the standard behavior analysis by adding methods such as intraepidermal nerve fiber (IENF) staining, a standard clinical tool for diagnosing peripheral neuropathies. Electrophysiology is conducted to study the functional properties of neurons enhancing the understanding of neurological disorders and the potential of neuroprotective or neurodegenerative therapies.
